Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTandem Diabetes Care, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 8 | -$0.63 | -$0.18 | -$0.46 |
| Q2 2025 | 5 | -$0.34 | -$0.31 | -$0.32 |
| Q3 2025 | 4 | -$0.26 | -$0.24 | -$0.25 |
| Q4 2025 | 5 | -$0.17 | -$0.16 | -$0.16 |
| Q1 2026 | 3 | -$0.38 | -$0.35 | -$0.36 |
| Q2 2026 | 4 | -$0.23 | -$0.21 | -$0.22 |
| Q3 2026 | 3 | -$0.18 | -$0.16 | -$0.17 |
| Q4 2026 | 4 | -$0.03 | -$0.03 | -$0.03 |
Tandem Diabetes Care, Inc. Earnings Date And Information
Tandem Diabetes Care, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.36 earnings per share for the quarter, topping analysts' consensus estimates of $-0.43 by $0.07. The company had revenue of 363.29 M for the quarter and had revenue of 747.72 M for the year. Tandem Diabetes Care, Inc. has generated $-3 earnings per share over the last year ($-3.43 diluted earnings per share) and currently has a price-to-earnings ratio of -18.5. Tandem Diabetes Care, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
Tandem Diabetes Care, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.43 | -$0.35 | 0.08 | $224.14 M | $363.29 M |
| 08/01/2024 | Q2 2024 | -$0.54 | -$0.47 | 0.07 | $205.63 M | $221.91 M |
| 05/02/2024 | Q1 2024 | -$0.80 | -$0.65 | 0.15 | $191.67 M | |
| 02/21/2024 | Q4 2023 | -$0.23 | -$0.46 | -0.23 | $196.80 M | |
| 11/01/2023 | Q3 2023 | -$0.35 | -$0.51 | -0.16 | $192.76 M | $185.62 M |
| 08/03/2023 | Q2 2023 | -$0.54 | -$0.55 | -0.01 | $197.62 M | $195.92 M |
| 05/03/2023 | Q1 2023 | -$0.56 | -$1.92 | -1.36 | $169.38 M | |
| 02/22/2023 | Q4 2022 | -$0.00 | -$0.25 | -0.25 | $220.50 M | |
| 11/02/2022 | Q3 2022 | -$0.05 | -$0.76 | -0.71 | $207.60 M | $204.55 M |
| 08/03/2022 | Q2 2022 | -$0.02 | -$0.23 | -0.21 | $205.21 M | $200.26 M |
| 05/04/2022 | Q1 2022 | -$0.07 | -$0.23 | -0.16 | $175.91 M | |
| 02/22/2022 | Q4 2021 | $0.21 | $0.17 | -0.04 | $210.00 M | |
| 11/03/2021 | Q3 2021 | $0.06 | $0.09 | 0.03 | $171.37 M | $179.63 M |
| 08/04/2021 | Q2 2021 | -$0.08 | $0.06 | 0.14 | $143.37 M | $172.14 M |
| 05/05/2021 | Q1 2021 | -$0.15 | -$0.08 | 0.07 | $141.04 M | |
| 02/24/2021 | Q4 2020 | $0.12 | $0.27 | 0.15 | $168.07 M | |
| 11/05/2020 | Q3 2020 | -$0.08 | -$0.15 | -0.07 | $115.33 M | $123.60 M |
| 07/30/2020 | Q2 2020 | -$0.24 | -$0.45 | -0.21 | $87.15 M | $109.24 M |
| 04/30/2020 | Q1 2020 | -$0.18 | -$0.25 | -0.07 | $97.93 M | |
| 02/24/2020 | Q4 2019 | -$0.05 | $0.04 | 0.09 | $108.40 M |
Tandem Diabetes Care, Inc. Earnings: FAQ's
When is Tandem Diabetes Care, Inc.'s earnings date?
Tandem Diabetes Care, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
Did Tandem Diabetes Care, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Tandem Diabetes Care, Inc. (:TNDM) reported $-0.36 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.43 by $0.07.
How can I listen to Tandem Diabetes Care, Inc.'s earnings conference
call?
The conference call for Tandem Diabetes Care, Inc.'s latest earnings report can be listened to online.
How can I read Tandem Diabetes Care, Inc.'s conference call transcript?
The conference call transcript for Tandem Diabetes Care, Inc.'s latest earnings report can be read online.
How much revenue does Tandem Diabetes Care, Inc. generate each year?
Tandem Diabetes Care, Inc. (:TNDM) has a recorded annual revenue of $747.72 M.
How much profit does Tandem Diabetes Care, Inc. generate each year?
Tandem Diabetes Care, Inc. (:TNDM) has a recorded net income of $747.72 M. Tandem Diabetes Care, Inc. has generated $-3.43 earnings per share over the last four quarters.
What is Tandem Diabetes Care, Inc.'s price-to-earnings ratio?
Tandem Diabetes Care, Inc. (:TNDM) has a price-to-earnings ratio of -18.5 and price/earnings-to-growth ratio is -2.42.